Literature DB >> 27564663

New Concepts in Alpha-1 Antitrypsin Deficiency Disease Mechanisms.

Stefan J Marciniak1, Adriana Ordóñez1, Jennifer A Dickens1, Joseph E Chambers1, Vruti Patel1, Caia S Dominicus1, Elke Malzer1.   

Abstract

Alpha-1 antitrypsin deficiency is predominantly caused by point mutations that alter the protein's folding. These mutations fall into two broad categories: those that destabilize the protein dramatically and lead to its post-translational degradation and those that affect protein structure more subtly to promote protein polymerization within the endoplasmic reticulum (ER). This distinction is important because it determines the cell's response to each mutant. The severely misfolded mutants trigger an unfolded protein response (UPR) that promotes improved protein folding but can kill the cell in the chronic setting. In contrast, mutations that permit polymer formation fail to activate the UPR but instead promote a nuclear factor-κB-mediated ER overload response. The ability of polymers to increase a cell's sensitivity to ER stress likely explains apparent inconsistencies in the alpha-1 antitrypsin-signaling literature that have linked polymers with the UPR. In this review we discuss the use of mutant serpins to dissect each signaling pathway.

Entities:  

Keywords:  endoplasmic reticulum overload; endoplasmic reticulum overload response; endoplasmic reticulum stress; serpin; unfolded protein response

Mesh:

Substances:

Year:  2016        PMID: 27564663     DOI: 10.1513/AnnalsATS.201506-358KV

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  10 in total

Review 1.  Endoplasmic reticulum stress in the pathogenesis of fibrotic disease.

Authors:  Jonathan A Kropski; Timothy S Blackwell
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

Review 2.  ER-phagy: mechanisms, regulation, and diseases connected to the lysosomal clearance of the endoplasmic reticulum.

Authors:  Fulvio Reggiori; Maurizio Molinari
Journal:  Physiol Rev       Date:  2022-02-21       Impact factor: 46.500

3.  ER-to-lysosome-associated degradation of proteasome-resistant ATZ polymers occurs via receptor-mediated vesicular transport.

Authors:  Ilaria Fregno; Elisa Fasana; Timothy J Bergmann; Andrea Raimondi; Marisa Loi; Tatiana Soldà; Carmela Galli; Rocco D'Antuono; Diego Morone; Alberto Danieli; Paolo Paganetti; Eelco van Anken; Maurizio Molinari
Journal:  EMBO J       Date:  2018-08-03       Impact factor: 11.598

Review 4.  Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicine.

Authors:  Craig P Hersh
Journal:  F1000Res       Date:  2017-11-27

Review 5.  Oxidative and endoplasmic reticulum stress in respiratory disease.

Authors:  Alice C-H Chen; Lucy Burr; Michael A McGuckin
Journal:  Clin Transl Immunology       Date:  2018-06-13

6.  Deep learning approach for quantification of organelles and misfolded polypeptide delivery within degradative compartments.

Authors:  Diego Morone; Alessandro Marazza; Timothy J Bergmann; Maurizio Molinari
Journal:  Mol Biol Cell       Date:  2020-05-13       Impact factor: 4.138

Review 7.  The Autophagy Pathway: A Critical Route in the Disposal of Alpha 1-Antitrypsin Aggregates That Holds Many Mysteries.

Authors:  Celine Leon; Marion Bouchecareilh
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

8.  ER, Mitochondria, and ISR Regulation by mt-HSP70 and ATF5 upon Procollagen Misfolding in Osteoblasts.

Authors:  Laura Gorrell; Elena Makareeva; Shakib Omari; Satoru Otsuru; Sergey Leikin
Journal:  Adv Sci (Weinh)       Date:  2022-08-21       Impact factor: 17.521

Review 9.  Endoplasmic reticulum turnover: ER-phagy and other flavors in selective and non-selective ER clearance.

Authors:  Ilaria Fregno; Maurizio Molinari
Journal:  F1000Res       Date:  2018-04-13

10.  Calcium signalling in mammalian cell lines expressing wild type and mutant human α1-Antitrypsin.

Authors:  Nancy T Malintan; Steven D Buckingham; David A Lomas; David B Sattelle
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.